Melanoma cancer clinical trials study investigational medications alone, or in combination with other study medications, or standard of care therapy.

Melanoma is a type of skin cancer that begins in the melanocyte cells. Melanoma is usually brown or black in appearance but can also show up as tan, pink, or white. It’s less common than other skin cancers, but it’s considered more serious because it has a greater likelihood of spreading.

Merkel cell carcinoma (MCC) is a rare form of skin cancer that is more likely than common skin cancers to spread. Once it has spread, it can be very difficult to treat.

There is a lot to consider when deciding whether to participate in a clinical trial. Any clinical trial includes risks, which the study doctor will review with you. Make sure you understand the risks before participating.

Resources for patients

For help understanding clinical trial listings and for other resources, visit the Patient Resources section.
Browse resources

About clinical trials

Learn what clinical trials are, how they work, and if you may be eligible to participate.
Learn more
This site is registered on wpml.org as a development site. Switch to a production site key to remove this banner.